Pruitt, Brachman become first Republican appointees to long-term care commission

Neil L. Pruitt Jr. and Judith Y. Brachman are the first GOP appointees to the long-term care commission created as part of January's fiscal cliff deal.

Their appointments were announced Monday, less than a week after House Minority Leader Nancy Pelosi named three people to the commission. Ultimately, 15 people will serve on the panel tasked with advising on how to improve the nation's long-term care system.

In addition to being chairman of the American Health Care Association Board of Governors, Pruitt is chairman and CEO of UHS-Pruitt Corporation. UHS-Pruitt encompasses more than 70 facilities providing skilled nursing and other post-acute care services in the southeastern United States. Senate Minority Leader Mitch McConnell (R-KY) made the appointment.

Brachman served as director of the Ohio Department of Aging from 1991-1999. She was named to the commission by another prominent public figure from Ohio, Republican Speaker of the House John Boehner. In other government posts, Brachman was president of the National Association of State Units on Aging and held an assistant secretary post at the Department of Housing and Urban Development. More recently, she served as co-chair of The Jewish Federations of North America's Aging and Family Caregiving Committee. She is a long-time JFNA board member.

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.